ENDRA LIFE SCIENCES INC. Adjustments to Additional Paid in Capital, Other
ENDRA LIFE SCIENCES INC. (NDRA) reported Adjustments to Additional Paid in Capital, Other of $1.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for the quarter ending 2026-06-30 was $1.21M.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for the quarter ending 2019-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $2.49M.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for the quarter ending 2018-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for fiscal 2019 was $2.49M, a 323.89% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. adjustments to additional paid in capital, other for fiscal 2018 was $587.54K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-14 | $1.21M 10-Q · filed 2026-08-14 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.49M derived: sum of 2 quarters · filed 2021-03-25 | $2.49M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $2.49M 10-Q · filed 2020-11-16 | $2.49M 10-Q · filed 2020-11-16 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $587.54K derived: sum of 3 quarters · filed 2020-03-26 | $587.54K 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $587.54K derived: sum of 2 quarters · filed 2019-11-13 | $587.54K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $587.54K 10-Q · filed 2019-08-08 | $587.54K 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |